Omnicell incorporated OMCL.US Overview Analysis
OMCL AI Analysis Overview
Keys for Bullish View
- Value≥4
- Dividend≥2
Analysis Conclusion
The stock has been awarded the top rating for its value, but its dividend score is below 2. If the company starts distributing dividends, it may yield even better investment results.
OMCL Current Performance
-0.08%
Omnicell incorporated
2.50%
Avg of Sector
0.74%
S&P500
Top 10 High Relevance to OMCL
Symbol | Company Name | Value | Trend | Swing Trading | Whale Interest | Dividend | Add to Watchlist |
---|---|---|---|---|---|---|---|
MASI | Masimo corporation | 4 | 5 | 4 | 2 | 1 | |
TECH | Bio-techne corp | 4 | 3 | 2 | 2 | 3 | |
FLGT | Fulgent genetics inc | 2 | 3 | 4 | 2 | 1 | |
ATRC | Atricure inc | 2 | 5 | 2 | 3 | 1 | |
WAT | Waters corp | 5 | 5 | 4 | 2 | 1 |
- MASI Masimo corporationValue 4Trend 5Swing Trading 4Whale Interest 2Dividend 1See more
OMCL Profile
Omnicell, Inc. is a provider of medication management solutions and adherence tools for health systems and pharmacies. The Company is focused on transforming pharmacy care through outcomes-centric innovation designed to optimize clinical and business outcomes across all settings of care through a portfolio of robotics, smart devices, intelligent software, and services. Its point of care automation solutions is designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The Company's XT Series automated dispensing systems for medications and supplies, which are used in nursing units and other clinical areas of the hospital, are designed to support workflows specific to each area of the hospital, with various software and hardware options. For the operating room, the Company also offer specialized automated dispensing systems.